Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 13/04/2022.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques importées :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | DEXMEDETOMIDINE EVER PHARMA | Dexmedetomidine | 400µg/4ml | SOL INJ PR PERF | B/5FL | EVER Valinject GmbH | N | 01/02/2022 | |
2 | DEXMEDETOMIDINE EVER PHARMA | Dexmedetomidine | 200µg/2ml | SOL INJ PR PERF | B/5FL | EVER Valinject GmbH | N | 01/02/2022 | |
3 | DEXMEDETOMIDINE EVER PHARMA | Dexmedetomidine | 1000µg/10ml | SOL INJ PR PERF | B/5FL | EVER Valinject GmbH | N | 01/02/2022 | |
4 | VESSEL | SULODEXIDE | 600UL | SOL INJ | B/10/2ML | ALFASIGMA | I | V | 01/02/2022 |
5 | VESSEL | SULODEXIDE | 250UL | SOL INJ | B/50 | ALFASIGMA | I | V | 01/02/2022 |
6 | JARDIANCE | EMPAGLIFLOZINE | 10 MG | COMP PEL | B/30 | BOEHRINGER INGELHEIM | E | V | 01/02/2022 |
7 | JARDIANCE | EMPAGLIFLOZINE | 25 MG | COMP PEL | B/30 | BOEHRINGER INGELHEIM | E | V | 01/02/2022 |
8 | SINGULAIR | MONTELUKAST | 10 mg | COMP | B/28 | ORGANON N.V HOLLLANDE | E | T | 01/02/2022 |
9 | SINGULAIR | MONTELUKAST | 5 mg | COMP | B/28 | ORGANON N.V HOLLLANDE | E | T | 01/02/2022 |
10 | CUROSURF | PHOSPHOLIPIDES TOTAUX | 120MG/1,5ML | SUSP | FL/1,5%M | CHIESI | V | V | 01/02/2022 |
11 | PULMICORT | BUDESONIDE | 0,5MG/0,2ML | SOL PR INH | 20 UNIDOSES | ASTRA ZENECA | E | V | 01/02/2022 |
12 | VIACORAM | PERINDOPRIL ARGININE+ AMLODIPINE | 7 mg/ 5 mg | COMP | PILULIER | SERVIER | E | R | 01/02/2022 |
13 | VIACORAM | PERINDOPRIL ARGININE+ AMLODIPINE | 3,5 mg/2,5 mg | COMP | PILULIER | SERVIER | E | R | 01/02/2022 |
14 | ZANIDIP | LERCANIDIPINE | 10 MG | COMP PEL SEC | B/30 | BOUCHARA RECARDATI | E | V | 01/02/2022 |
15 | UPTRAVI | SELEXIPAG | 200µG | COMP PEL | B/140 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
16 | UPTRAVI | SELEXIPAG | 200µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
17 | UPTRAVI | SELEXIPAG | 400µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
18 | UPTRAVI | SELEXIPAG | 600µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
19 | UPTRAVI | SELEXIPAG | 800µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
20 | UPTRAVI | SELEXIPAG | 1000µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
21 | UPTRAVI | SELEXIPAG | 1200µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
22 | UPTRAVI | SELEXIPAG | 1400µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
23 | UPTRAVI | SELEXIPAG | 1600µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
24 | BRIDION | SUGAMMADEX | 100MG/ML | Sol Inj | B/10/2ML | MSD-Pays Bas | E | N | 28/02/2022 |
25 | TELFAST | FEXOFENADINE | 180 mg | CP PELL | B/15 | OPELLA France | E | N/T | 01/03/2022 |
26 | TELFAST | FEXOFENADINE | 120 mg | CP PELL | B/15 | OPELLA France | E | N/T | 01/03/2022 |
27 | ASPEGIC | ACETYLSALICYLATE DE LYSINE | 1 GR | PDRE PR PREP INJ | B/6+S/5ML | OPELLA HEALTHACARE FRANCE SAS | E | T | 25/03/2022 |
28 | ASPEGIC | ACETYLSALICYLATE DE LYSINE | 500 MG | PDRE PR PREP INJ | B/6+S/5ML | OPELLA HEALTHACARE FRANCE SAS | E | T | 25/03/2022 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | DEXMEDETOMIDINE EVER PHARMA | Dexmedetomidine | 400µg/4ml | SOL INJ PR PERF | B/5FL | EVER Valinject GmbH | N | 01/02/2022 | |
2 | DEXMEDETOMIDINE EVER PHARMA | Dexmedetomidine | 200µg/2ml | SOL INJ PR PERF | B/5FL | EVER Valinject GmbH | N | 01/02/2022 | |
3 | DEXMEDETOMIDINE EVER PHARMA | Dexmedetomidine | 1000µg/10ml | SOL INJ PR PERF | B/5FL | EVER Valinject GmbH | N | 01/02/2022 | |
4 | VESSEL | SULODEXIDE | 600UL | SOL INJ | B/10/2ML | ALFASIGMA | I | V | 01/02/2022 |
5 | VESSEL | SULODEXIDE | 250UL | SOL INJ | B/50 | ALFASIGMA | I | V | 01/02/2022 |
6 | JARDIANCE | EMPAGLIFLOZINE | 10 MG | COMP PEL | B/30 | BOEHRINGER INGELHEIM | E | V | 01/02/2022 |
7 | JARDIANCE | EMPAGLIFLOZINE | 25 MG | COMP PEL | B/30 | BOEHRINGER INGELHEIM | E | V | 01/02/2022 |
8 | SINGULAIR | MONTELUKAST | 10 mg | COMP | B/28 | ORGANON N.V HOLLLANDE | E | T | 01/02/2022 |
9 | SINGULAIR | MONTELUKAST | 5 mg | COMP | B/28 | ORGANON N.V HOLLLANDE | E | T | 01/02/2022 |
10 | CUROSURF | PHOSPHOLIPIDES TOTAUX | 120MG/1,5ML | SUSP | FL/1,5%M | CHIESI | V | V | 01/02/2022 |
11 | PULMICORT | BUDESONIDE | 0,5MG/0,2ML | SOL PR INH | 20 UNIDOSES | ASTRA ZENECA | E | V | 01/02/2022 |
12 | VIACORAM | PERINDOPRIL ARGININE+ AMLODIPINE | 7 mg/ 5 mg | COMP | PILULIER | SERVIER | E | R | 01/02/2022 |
13 | VIACORAM | PERINDOPRIL ARGININE+ AMLODIPINE | 3,5 mg/2,5 mg | COMP | PILULIER | SERVIER | E | R | 01/02/2022 |
14 | ZANIDIP | LERCANIDIPINE | 10 MG | COMP PEL SEC | B/30 | BOUCHARA RECARDATI | E | V | 01/02/2022 |
15 | UPTRAVI | SELEXIPAG | 200µG | COMP PEL | B/140 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
16 | UPTRAVI | SELEXIPAG | 200µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
17 | UPTRAVI | SELEXIPAG | 400µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
18 | UPTRAVI | SELEXIPAG | 600µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
19 | UPTRAVI | SELEXIPAG | 800µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
20 | UPTRAVI | SELEXIPAG | 1000µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
21 | UPTRAVI | SELEXIPAG | 1200µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
22 | UPTRAVI | SELEXIPAG | 1400µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
23 | UPTRAVI | SELEXIPAG | 1600µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
24 | BRIDION | SUGAMMADEX | 100MG/ML | Sol Inj | B/10/2ML | MSD-Pays Bas | E | N | 28/02/2022 |
25 | TELFAST | FEXOFENADINE | 180 mg | CP PELL | B/15 | OPELLA France | E | N/T | 01/03/2022 |
26 | TELFAST | FEXOFENADINE | 120 mg | CP PELL | B/15 | OPELLA France | E | N/T | 01/03/2022 |
27 | ASPEGIC | ACETYLSALICYLATE DE LYSINE | 1 GR | PDRE PR PREP INJ | B/6+S/5ML | OPELLA HEALTHACARE FRANCE SAS | E | T | 25/03/2022 |
28 | ASPEGIC | ACETYLSALICYLATE DE LYSINE | 500 MG | PDRE PR PREP INJ | B/6+S/5ML | OPELLA HEALTHACARE FRANCE SAS | E | T | 25/03/2022 |